Search Results - "Miao, Chensi"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Systematically investigating the key features of the DNase deactivated Cpf1 for tunable transcription regulation in prokaryotic cells by Miao, Chensi, Zhao, Huiwei, Qian, Long, Lou, Chunbo

    Published in Synthetic and systems biotechnology (01-03-2019)
    “…With a unique crRNA processing capability, the CRISPR associated Cpf1 protein holds great potential for multiplex gene regulation. Unlike the well-studied Cas9…”
    Get full text
    Journal Article
  2. 2

    Protein language models-assisted optimization of a uracil-N-glycosylase variant enables programmable T-to-G and T-to-C base editing by He, Yan, Zhou, Xibin, Chang, Chong, Chen, Ge, Liu, Weikuan, Li, Geng, Fan, Xiaoqi, Sun, Mingsun, Miao, Chensi, Huang, Qianyue, Ma, Yunqing, Yuan, Fajie, Chang, Xing

    Published in Molecular cell (04-04-2024)
    “…Current base editors (BEs) use DNA deaminases, including cytidine deaminase in cytidine BE (CBE) or adenine deaminase in adenine BE (ABE), to facilitate…”
    Get more information
    Journal Article
  3. 3

    Engineering the Ultrasensitive Transcription Factors by Fusing a Modular Oligomerization Domain by Hou, Junran, Zeng, Weiqian, Zong, Yeqing, Chen, Zehua, Miao, Chensi, Wang, Baojun, Lou, Chunbo

    Published in ACS synthetic biology (18-05-2018)
    “…The dimerization and high-order oligomerization of transcription factors has endowed them with cooperative regulatory capabilities that play important roles in…”
    Get full text
    Journal Article
  4. 4

    Abstract 4999: Characterization of myeloid derived suppressor cells after capecitabine and nivolumab combination treatment by Lin, Qing, Wang, Tienan, Yan, Wenjun, Wu, Ranran, Nie, Lun, Miao, Chensi, Wang, Xing, Wang, Feng, Zhang, Jie, Shi, Weilin, Yuan, Yanping, Shi, Tingting, Li, Ao, Dong, Wei, Chen, Xu, Sun, Jingying, Ji, Qunsheng

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Capecitabine, a widely used oral chemotherapeutic agent, only functions in its active form, 5-FU. The metabolism of capecitabine to 5-FU frequently…”
    Get full text
    Journal Article
  5. 5

    Engineering Translational Activators with CRISPR-Cas System by Du, Pei, Miao, Chensi, Lou, Qiuli, Wang, Zefeng, Lou, Chunbo

    Published in ACS synthetic biology (15-01-2016)
    “…RNA parts often serve as critical components in genetic engineering. Here we report a design of translational activators which is composed of an RNA…”
    Get full text
    Journal Article
  6. 6